Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
BMJ Case Reports|October 3, 2018
Hypoxic hepatitis and furosemideAna Carina Pizzarossa, Martín RebellaBMJ Case Reports|January 31, 2019
Hepatitis in patients with syphilis: an overlooked associationAna Carina Pizzarossa, Martín RebellaRevista Medica De Chile|December 21, 2019
[Etiology of renal infarction. A systematic review]Ana Carina Pizzarossa, Valentina MérolaJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 9, 2017
The Clinician Faced With Anticochlear Antibodies: What to Do With Them?Adriana Carlomagno, Gonzalo Silveira, Martín Rebella, et al.Revista Medica De Chile|June 26, 2023
[Off-label use of mycophenolate mofetil in immune-mediated diseases]Alvaro Danza, Diego Graña, Cecilia Casas, et al.Lupus|March 30, 2022
Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot studyAlvaro Danza, Diego Graña, Evelyn Soto, et al.Lupus|March 25, 2025
Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patientsGonzalo Silveira, Sabrina Ranero, Adriana Carlomagno, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 27, 2024
Venous Thromboembolism Risk and Adherence to Pharmacological Thromboprophylaxis in Hospitalized Patients in Uruguay: First Nationwide StudyValentina Mérola, Ana Carina Pizzarossa, Maynés López, et al.Lupus|April 28, 2026
Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohortsRosana Quintana, Lucia Hernández, Guillermo Pons-Estel, et al.Lupus|January 29, 2021
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study GroupJosé A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, et al.Pageof 1